Latest Asx News

Peregrine Gold Limited has announced significant progress across its Pilbara projects, including new sampling programs targeting gold anomalies and approvals for drilling at key prospects. The company’s latest assays and heritage agreements set the stage for upcoming exploration activities.

Rincon Resources has agreed to sell its Laverton assets to Galleon Metals, receiving shares in return, while preparing to sell or joint venture its West Arunta project as it concentrates on its Telfer South and Crackerbox projects.

Commonwealth Bank of Australia has updated its interim dividend details, confirming a fully franked payout of AUD 2.35 per share with multi-currency payment options and a Dividend Reinvestment Plan participation of 13.5%.

PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.

Mach7 Technologies has completed its on-market share buy-back, acquiring over six million shares at an average price well below the initial $5 million cap. The move signals a cautious but confident approach to capital management amid evolving market conditions.

Brightstar Resources has completed a US$120 million senior secured bond issue, complementing a recent A$193 million equity raise, to fully fund its Goldfields Project and advance the Sandstone Project towards final investment decision.

Complii FinTech Solutions has locked in $2 million through a convertible note raising to fund key platform upgrades and strategic expansions across its business units.

Wia Gold’s latest drilling results at the Kokoseb Gold Project in Namibia reveal significant high-grade gold mineralisation extending well beyond the current open-pit resource, boosting underground mining prospects.

Kairos Minerals has delivered strong final drill results from its Mt York Gold Project, underpinning an updated resource estimate and an ambitious drilling program planned for 2026.

Island Pharmaceuticals has entered a pivotal research agreement with USAMRIID and the Geneva Foundation to accelerate FDA approval of Galidesivir for Marburg Virus Disease, leveraging top-tier US biodefense expertise.

Unith Ltd has launched its Streaming Avatars technology, delivering a dramatic latency reduction and validated by strong customer feedback, setting a new standard for real-time digital human interactions.

Australian Vanadium Limited has raised $7.5 million through a targeted placement to accelerate its vertically integrated vanadium strategy, including the Kalgoorlie battery energy storage project.